<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00270777</url>
  </required_header>
  <id_info>
    <org_study_id>178A07</org_study_id>
    <nct_id>NCT00270777</nct_id>
  </id_info>
  <brief_title>Improving Safety of Antivenom in People Bitten by Snakes</brief_title>
  <official_title>Low Dose Adrenaline, Promethazine, &amp; Hydrocortisone (Alone and in Combination) to Prevent Acute Adverse Reactions to Antivenom in People Bitten by Snakes: Randomised, Double Blind, Placebo-Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kelaniya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kelaniya</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to increase the safety of polyvalent antivenom involving 1000 patients in three
      centres: low dose adrenaline, promethazine, &amp; hydrocortisone (alone and in combination) to
      prevent acute adverse reactions to antivenom in people bitten by snakes: randomised, double
      blind, placebo-controlled trial.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of severe reactions to antivenom in the first 48 hours</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of moderate &amp; severe reactions to antivenom in the first 48 hours</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Snake Bites</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>adrenaline, promethazine, hydrocortisone</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Above 12 years of age

          -  Patients admitted to hospital after snake bite in whom antivenom is indicated

          -  Patients who give informed consent

        Exclusion Criteria:

          -  Patients who are pregnant or nursing

          -  Patients who are currently taking beta- or alpha-adrenoceptor antagonists, or
             tricyclic antidepressants

          -  Patients in whom adrenaline may be contraindicated (this may include patients with the
             following: history of ischaemic heart disease, stroke, uncontrolled hypertension, and
             tachyarrhythmias)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Asita de Silva</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kelaniya</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Trials Unit, University of Kelaniya</name>
      <address>
        <city>Ragama</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sri Lanka</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2005</study_first_submitted>
  <study_first_submitted_qc>December 27, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2005</study_first_posted>
  <last_update_submitted>June 4, 2008</last_update_submitted>
  <last_update_submitted_qc>June 4, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2008</last_update_posted>
  <keyword>Controlled trial</keyword>
  <keyword>Snake bite</keyword>
  <keyword>Safety</keyword>
  <keyword>Antivenom</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Snake Bites</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Diphenhydramine</mesh_term>
    <mesh_term>Promethazine</mesh_term>
    <mesh_term>Antivenins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

